Add this topic to your myFT Digest for news straight to your inbox
Continent’s drugmakers need to pay up to attract and retain talent, says Pascal Soriot
Rishi Sunak has vowed to get people back to work but data indicates problems with the diagnosis — and proposed solution
Neglecting women’s pain affects the entire medical pipeline, from research to diagnosis and treatment
Admonitions about staff trading in their employer’s shares may now need to be broadened
Judge to decide on admission of evidence as part of litigation that has knocked billions off pharma group’s value
Swiss pharma group has jettisoned 16 drugs that ‘don’t have the promise to be transformative medicines’
Businesses can keep exploiting our tiredness while scientists seek to explain the mechanics of it
WPP-owned advertising agency seeks to tap trend for seeking medical information on social media
Technique highlights concerns shifting global disease burden as populations age
Rate of fatalities from excessive drinking 41% higher in 2022 than 2019, with women showing the biggest rise
Pfizer’s Emblaveo to be aimed at some of the most dangerous drug-resistant bacteria
High costs and concerns over efficacy and side effects limit uptake of first treatment as another nears approval
Garden gnomes; big pharma; intelligent insects; four-day work week
Paul Keel in line for multimillion-dollar pay rise despite jumping to a company half Smiths’ size
Ochre Bio partnering with Germany’s Boehringer Ingelheim on treatments that will harness the organ’s capacity to regenerate
Moderna alleges Pfizer and BioNTech infringed its patents in use of mRNA platform
Factory inspectors refuse to visit country over fears they could fall foul of tightened rules
A population equivalent in size to Greater Manchester is not working due to ill health, at a huge and avoidable cost
Report from Nuffield Trust health think-tank highlights impact of leaving EU on medicine supply chains
Research harnesses power of generative artificial intelligence in latest sign of its potential use in medicine
Study results could encourage US Medicare system and private insurers to cover tirzepatide treatments
Almost 60 Conservatives oppose bill to stop anyone born after 2009 from ever being sold cigarettes legally
Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
Michel Demaré in FT hits out at ISS and Glass Lewis for applying ‘double standards’ after they opposed CEO pay package
Almost 36 per cent of shareholders voted against a £1.8mn rise for the pharma group’s boss
International Edition